Lymphatic Occlusion Pressure in Lower Limb
The Occlusion Pressure of Superficial Lymphatics in the Lower Extremity of Healthy Volunteers: A Near Infrared Lymphofluoroscopy Approach
1 other identifier
interventional
32
1 country
1
Brief Summary
The lymphatic system is one of the keystones of fluid homeostasis in the interstitium. In analogy with the arterial systolic pressure, the lymphatic pressure can give us information about the functioning of the cardiovascular system and fluid exchange. Actually, knowledge about this physiological parameter is incomplete because of the lack of technology. Former measurement techniques of the lymphatic pressure in the living healthy man were invasive and too complex to be interpreted. The lymphatic occlusion pressure has to be clarified because lymphedema treatment, concerning the pressure to be applied on the edematous tissue is still based on controversial concepts. On one hand, techniques such as Manual Lymphatic Drainage, sustain the necessity to apply a very low pressure in order to avoid the squeezing of superficial lymph vessels. On the other hand sustainers of Intermittent Compression Therapy advocate the necessity to apply relatively high pressure to obtain a decongesting effect. These completely opposite opinions triggered us to study lymphatic pressure more thoroughly. Lymphofluoroscopy (emerging imaging technique in the field of lymphology) is now used since 3 years by the promoters of this study to visualize the architecture of the superficial lymphatic network and the progression of the lymph inside the highlighted vessels. This technique will be used in the present (prospective and multicentric) study to observe the effect of a pressure applied on the lower limb on the displacement of the lymph, and then to determine the occlusion pressure of the lymphatic vessels. The investigators already studied the occlusion pressure of the superficial lymphatic vessels of the upper limb in a previous study. The investigators would like to complete our results with the lower limb.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started May 2015
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2015
CompletedFirst Posted
Study publicly available on registry
April 1, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedApril 1, 2015
March 1, 2015
7 months
March 5, 2015
March 31, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Lymph flow active or not, depending on the pressure applied
The sphygmomanometer is connected to a pressure meter, indicating mm of Mercury (Testo® 510 Digital Manometer precision 0.1mmHg.).
1 minute
Study Arms (1)
Lymphatic occlusion pressure lower limb
EXPERIMENTALinjection of 100µg Indocyanine Green in the first interdigital space and application of increasing pressure around the leg to visualize at which pressure lymph flow is interrupted.
Interventions
Intradermal injection of Indocyanine Green in the first interdigital space of the studied leg
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Written informed consent signed
You may not qualify if:
- Coronary disease
- Pregnancy
- Allergy to iodine or to shellfish
- Breastfeeding
- Advanced renal impairment
- Minors
- Thyroid pathology
- Primary and secondary lymphedema anywhere on the body
- Oncologic history
- Familial lymphedema
- Previous surgery on the studied member, causing risk of a subclinical lymphedema
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU St-Pierre - Lymphology Clinic of Brussels
Brussels, 1000, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Paul Belgrado
CHU St-Pierre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2015
First Posted
April 1, 2015
Study Start
May 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
April 1, 2015
Record last verified: 2015-03